Clinical feature	Statistical test	Significant miRs	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
DAYS_TO_DEATH_OR_LAST_FUP	Cox regression test	N=0	 	 	 	 
YEARS_TO_BIRTH	Spearman correlation test	N=30	older	N=19	younger	N=11
PATHOLOGY_T_STAGE	Spearman correlation test	N=30	higher stage	N=7	lower stage	N=23
PATHOLOGY_N_STAGE	Wilcoxon test	N=30	n1	N=30	n0	N=0
HISTOLOGICAL_TYPE	Wilcoxon test	N=13	prostate adenocarcinoma acinar type	N=13	prostate adenocarcinoma  other subtype	N=0
COMPLETENESS_OF_RESECTION	Kruskal-Wallis test	N=30	 	 	 	 
NUMBER_OF_LYMPH_NODES	Spearman correlation test	N=30	higher number_of_lymph_nodes	N=12	lower number_of_lymph_nodes	N=18
GLEASON_SCORE_COMBINED	Spearman correlation test	N=30	higher score	N=13	lower score	N=17
GLEASON_SCORE_PRIMARY	Spearman correlation test	N=30	higher score	N=13	lower score	N=17
GLEASON_SCORE_SECONDARY	Spearman correlation test	N=30	higher score	N=17	lower score	N=13
GLEASON_SCORE	Spearman correlation test	N=30	higher score	N=12	lower score	N=18
PSA_RESULT_PREOP	Spearman correlation test	N=30	higher psa_result_preop	N=13	lower psa_result_preop	N=17
PSA_VALUE	Spearman correlation test	N=30	higher psa_value	N=9	lower psa_value	N=21
RACE	Kruskal-Wallis test	N=0	 	 	 	 
